Jessica Moon, PhDFDA Approves Cobenfy for SchizophreniaTargeting a New Pathway for Improved Patient Outcomes5d ago5d ago
Jessica Moon, PhDA Quick Peek Inside DARPAKey Insights from a Fireside Chat with Stephanie Tompkins, DirectorAug 30Aug 30
Jessica Moon, PhDUnlocking Market Access with Medicare’s New TCET PathwayMedicare’s new pathway promises faster market access, greater transparency, and more control for innovators — here’s what you need to know.Aug 8Aug 8
Jessica Moon, PhDWhy SBIR/STTR Funding Should Be on Every Founder’s RadarUnderstanding the Untapped Potential of Government Grants for Your StartupAug 6Aug 6
Jessica Moon, PhDHow I protect my mental health while making a career transitionCareer transitions always take much longer than one expects/hopes and mine to VC is no exception. This is how I’m sticking with it for the…Jul 15Jul 15
Jessica Moon, PhDMini Market Dive: Sleep TechA short overview of how the sleep tech market has evolved since the 90s.Jul 7Jul 7
Jessica Moon, PhDSofdra Wins FDA Approval: A Game-Changer for HyperhidrosisFDA approves the first drug for excessive underarm sweatingJul 2Jul 2
Jessica Moon, PhDGLP-1 agonists like semaglutide may be a promising tool for combating addiction in the U.S.Jun 13Jun 13
Jessica Moon, PhDSemaglutide Poised to Disrupt the Cardiovascular Drug MarketWelcome to my series on recent FDA drug and device approvals, where we explore groundbreaking new biomedical innovations and their…Jun 6Jun 6